John F. Crowley is CEO of Amicus Therapeutics. Crowley’s involvement with biotechnology stems from the 1998 diagnosis of two of his children with Pompe disease—a severe and often fatal ...
When Megan was diagnosed with an extremely rare disease as a baby, her father, John Crowley, founded a small biotechnology start-up to try to cure Megan and her brother — an effort that ...
The event brings together biopharmaceutical professionals, government officials, academic leaders and professional service ...
“Our adversaries abroad have stated that they intend to become the biotechnology centre of excellence in the world,” said BIO’s new chief executive, John Crowley, in a statement. “America ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback